Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 2 1

Status

Completed 11Terminated 2

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Breast 1

Conditions

Tobacco Use Cessation 1Hand-Foot Syndrome 1HIV Seropositivity 1Breast Neoplasms 1Acquired Immunodeficiency Syndrome 1

Interventions

Cyclophosphamide 222pembrolizumab 201Carboplatin 173Cisplatin 168Gemcitabine 167Paclitaxel 155Docetaxel 140Bevacizumab 138Rituximab 137Radiotherapy 137Nivolumab 126Dexamethasone 126Capecitabine 103fludarabine 102Pemetrexed 92fludarabine phosphate 91Fluorouracil 91Doxorubicin 85Oxaliplatin 79Etoposide 77Cytarabine 77Bortezomib 76Erlotinib Hydrochloride 74Leucovorin 72Filgrastim 68Lenalidomide 67Calcium Dobesilate 66Irinotecan 65atezolizumab 63Radiation 61

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Terminated × Has results × Tobacco Use Cessation Devices × Clear all
NCT00751101 2020-10-05

Nicotine Patches in Reducing Hand-Foot Syndrome in Patients Who Are Receiving Capecitabine For Metastatic Breast Cancer

University of California, San Francisco

Phase 2 Terminated
24 enrolled 12 charts
Breast

Breast Neoplasms, Hand-Foot Syndrome

NCT02302859 2020-01-27

Mobile Media-Rich Interactive Guideline System (MMRIGS) Pilot Study

M.D. Anderson Cancer Center

Phase NA Terminated
8 enrolled 3 charts

Acquired Immunodeficiency Syndrome, HIV Seropositivity, Tobacco Use Cessation

Data powered by HemOnc (CC BY 4.0) Colophon âš¡